Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Biographical Sketch
Valerie E. Kalinowski, M.D., M.H.A., is Medical Director of the Pediatric Intensive Care Unit and Staff Physician in Cleveland Clinic Children’s Hospital Department of Pediatric Critical Care Medicine.
Dr. Kalinowski is board certified in both pediatrics and pediatric critical care medicine. In addition, she holds certifications in advanced trauma life support and pediatric advanced life support. She earned her medical degree from George Washington University School of Medicine in Washington, D.C., and completed a Master’s of Health Administration at the University of North Carolina School of Public Health. Her post-graduate training includes a pediatric residency at University of California-San Diego and a pediatric critical care medicine fellowship at Rady Children’s Hospital in San Diego.
Dr. Kalinowski is a member of several professional organizations, including the Society of Critical Care Medicine, American Academy of Pediatrics, and the American Medical Association.
In addition to her clinical appointment, Dr. Kalinowski also serves on several committees, including the Pediatric Institute’s Oversight Committee, Hand Hygiene Committee, and the Pediatric Infection Control Committee. She also currently serves as Co-chair of the Pediatric Critical Response Committee and Medical Director of Pediatric Respiratory Therapy.
Her specialty interests include ARDS, heart failure, congenital heart disease, transplant medicine, and transport of the critically ill child.
Specialty Interests
cardiac critical care, infectious diseases, pediatric and adolescent intensive care, pediatric critical care medicine
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 3/12/2010, Dr. Kalinowski has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.